Risperdal use OK'd in treating children
Pediatric study of antipsychotic drug considered rarity
WASHINGTON -- The Food and Drug Administration yesterday approved the antipsychotic drug Risperdal to treat children with schizophrenia and bipolar disorder. (Full article: 644 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass
